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1. Can the authors find a more informative reference for the targets of norepinephrine. It is unusual that NE only targets one of the three beta-adrenergic receptors. Additionally the review/commentary referenced does not reflect the information presented in the text (regarding receptors). Is this statement relevant to a particular organ? 2. 'Hence it can be suggested that the differences seen in level of endogenous NE could be due to different rates of absorption determined by the route of administration.' -is it possible for the authors to briefly elaborate on the implications of route of administration, perhaps suggest/speculate which of the two main routes is safer? 3. 'to mimic the sympathetic hyperactivity observed in obesity and type 2 diabetes.' -could the authors please provide a reference for this particular statement. 4. Can the authors provide very basic labelling of the points highlighted in Figure 1 .
